Composition comprising antisense oligonucleotide and use thereof for treatment of duchenne muscular dystrophy
MYPI2025000949A0Undetermined Publication Date: 2019-12-26NIPPON SHINYAKU CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025000949
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-10-01
- Filing Date
- 2019-06-26
- Publication Date
- 2019-12-26
Abstract
The present invention relates to a composition containing an antisense oligonucleotide, and the use thereof to treat Duchenne muscular dystrophy. The present invention particularly relates to the above-described composition that is effective for the treatment of Duchenne muscular dystrophy when it is administered at a dose for the treatment, and the use thereof.
Need to check novelty before this filing date? Find Prior Art
